coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Macclesfield PCN, Cheshire East (LAD) · Health Inequalities Profile

    PCN U82612 · NHS Cheshire and Merseyside Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    62,807

    Registered population

    60.0% aged 18–64

    22.4%

    Aged 65+

    ICB 19.0% · England 17.9%

    5.4%

    Ethnic minority (non-White)

    2.3% Asian · England 9.6%

    4.9%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~3,145

    Core20 residents (est.)

    see page 3

    11,107

    Hypertension register

    +6.71% in 3 yrs · England +5.60%

    718

    SMI register

    18.1% of Cheshire East (LAD)'s

    1,342

    COPD register

    Reviews -4.20% in 3 yrs

    Forecast to 2030

    13,053

    Hypertension patients, 2030

    +1,946 on today

    68.2%

    QRISK ≥20% on statins, 2030

    +1.99pp over 3 yrs

    5.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    1,384
    Asthma review rate fell over three years.

    Annual asthma reviews reached 68.3% after falling 1.0% over three years (England +4.4%), leaving a scale estimate of about 1,400 of 4,363 patients unreviewed.

    -4.2%
    COPD review rate trails England after fall.

    COPD annual reviews fell 4.2% over three years while England rose +2.8%, leaving coverage at 73.1% against 76.4% nationally, which could reflect recall fatigue.

    74.5%
    Hypertension control and heart failure reviews lead.

    Hypertension treated to target reaches 74.5% (England 70.3%, Cheshire East 69.8%) and annual heart failure reviews reach 85.2% (England 78.5%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older adults comprise 22.4% of patients, exceeding England alongside 809 care home beds

    Across 62,807 registered patients, 22.4% (14,081) are aged 65+, in line with Cheshire East (22.6%) but above the ICB (19.0%) and England (17.9%). Children aged 0-17 make up 17.6% (11,027) and adults aged 18-64 represent 60.0% (37,699). Census figures—reflecting resident area populations rather than registered patients—indicate 94.6% White ethnicity (Cheshire East 94.4%, ICB 93.0%, England 81.1%) and a 5.4% ethnic minority share, including 2.3% Asian or Asian British residents. List size is projected to grow 2.9% to 2030 under unverified projection methods.

    Age profile

    0–1717.6%
    18–6460.0%
    65+22.4%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White94.6%
    Asian2.3%
    Mixed1.7%
    Black0.8%
    Other0.7%

    Older people · falls rows are Cheshire East (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Cheshire East LA)2,1292,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.7%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)61.1%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Cheshire East LA)9391,0219552024/25
    Falls deaths, all ages, per 100,000 (Cheshire East LA)14.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation is low PCN-wide at 4.9% Core20 but varies across practices

    The PCN average IMD decile is 6.4, compared with 7.1 in Cheshire East (LAD), 5.2 in the ICB, and 5.5 in England. The Core20 share is 4.9%, below Cheshire East (9.2%), the ICB (31.9%), and England (21.0%). Practice concentration spans 1.6 pp, from 4.5% at Park Lane Surgery to 6.2% at Broken Cross Surgery. However, resident Core20 estimates (3,145 people across two deprived LSOAs) do not reconcile with practice-level registered lists, requiring careful validation before workload targeting.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Broken Cross6.2% · 366 patients
    High Street5.9% · 395 patients
    South Park5.2% · 625 patients
    Cumberland House4.9% · 733 patients
    Park Green4.9% · 631 patients
    Park Lane4.5% · 471 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    718

    SMI register

    1.14% recorded prevalence

    405

    Learning disability register

    0.64% recorded prevalence

    21

    Care homes, 809 beds

    In the PCN catchment

    8.8%

    Provide unpaid care

    Cheshire East (LAD), Census 2021

    The PCN records 718 patients on the severe mental illness register (1.1%) and 405 with learning disabilities (0.6%), alongside 809 beds across 21 catchment care homes. Cheshire East records 10 people sleeping rough in the autumn 2025 snapshot, and the PCN has an unvalidated ceiling estimate of about 5,500 unpaid carers.

    Severe mental illness: physical health checks

    SMI blood pressure check coverage is 82.0% (England 83.4%), rising +0.9 pp over three years (2023 to 2025; England +4.4 pp). SMI recorded BMI is 79.5% (England 82.1%). Both indicators exceed Cheshire East (79.0% and 77.9%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    11,107

    Hypertension register

    +6.71%

    Register growth, 3 yrs

    Cheshire East (LAD) +6.54% · England +5.60%

    +3.42pp

    BP control, under 80

    ≤140/90 · +2.77pp aged 80+

    +1,946

    More patients by 2030

    Forecast 13,053 (20.11%)

    Hypertension case-finding and control

    Hypertension register prevalence is 17.7% (11,107 patients), exceeding Cheshire East (17.3%), NHS Cheshire and Merseyside Integrated Care Board (16.8%), and England (15.2%). Among registered patients, 74.5% are treated to target (England 70.3%, Cheshire East 69.8%, ICB 69.1%). In addition, 90.0% have a recent blood pressure reading (England 90.0%, Cheshire East 88.4%, ICB 88.3%). Over three years (2023 to 2025), recent checks rose +0.5%, trailing Cheshire East (+2.1%), the ICB (+2.6%), and England (+3.6%). Observation periods for registers and current achievement were not captured. Slower three-year growth in blood pressure checks could reflect recall gaps, testable through practice recall audits.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reached 64.1%, above Cheshire East (61.2%), NHS Cheshire and Merseyside Integrated Care Board (63.2%), and England (63.6%). Three-year change rose +3.2% (2023 to 2025), trailing gains across England (+6.2%), Cheshire East (+6.3%), and the ICB (+5.2%).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026142,660£1.70£1.71£1.86£242,522
    Cardiovascular (all), 2025186,501£2.98£4.37£3.33£555,773

    For lipid-regulating drugs in 2026, the PCN prescribed 142,660 items at £1.70 per item, below Cheshire East (£1.72), NHS Cheshire and Merseyside Integrated Care Board (£1.71), and England (£1.86). Across these 142,660 items, spend was £22,826 less than at England's unit cost and £1,427 less than at the ICB's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −0.96%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.64%

    Asthma prevalence, PCN 3-yr % change

    Asthma reviews reached 68.3% (England 65.7%), but fell 1.0% over three years (2023 to 2025; England +4.4%), leaving a modelled gap of 1,384 (about 1,400) of 4,363 patients unreviewed. COPD reviews fell 4.2% (England +2.8%) to 73.1% (England 76.4%, Cheshire East 74.5%). For ages 5–19, asthma management items reached 2,011 per 1,000 (England 1,488; Cheshire East 1,586). Falling review trajectories could reflect post-pandemic recall fatigue, testable by auditing practice recall lists.

    Cancer register and children's immunisation

    In Q1 2025/26, 6-in-1 coverage at 12 months was 98.6% (denominator 144), exceeding the 95.0% target. At age five (cohort 122), MMR dose 1 was 96.7% while dose 2 was 91.0%, a 5.7 pp difference that sits 4 pp below the 95.0% target. Cancer register prevalence is 4.6% (2,885 patients; England 3.8%, Cheshire East 4.9%).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months98.6%

    England 91.0%

    6-in-1 complete primary course at 24 months94.3%

    England 92.2%

    MMR dose 1 at 24 months94.3%

    England 88.3%

    MMR dose 2 at age 591.0%

    England 82.8%

    4-in-1 pre-school booster at age 591.8%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Across NHS Cheshire and Merseyside ICB in 2022, 55.5% of cancers with a known stage were diagnosed at stage 1 or 2 (7,482 of 13,490 staged cases), in line with England (55.3%) but 19.5 pp below the 75.0% national ambition by 2028. A known stage was recorded for 72.8% of all registered cancers (13,490 of 18,522). Reaching the 75.0% ambition across the ICB would require about 2,640 additional early-stage diagnoses annually. Staging data is captured at ICB level rather than PCN level, describing wider system pathways rather than PCN performance. System-wide late staging increases the importance of proactive practice-level referral and safety-netting.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional July 2026 data, East Cheshire NHS Trust met the 28-day faster diagnosis standard at 81.1% (standard 75.0%; England 79.3%) and the 31-day treatment standard at 96.3% (standard 96.0%; England 92.5%). However, its 62-day referral-to-treatment rate was 53.4%, below the 85.0% standard by 31.6 pp, trailing Stockport NHS Foundation Trust (74.7%), Manchester University NHS Foundation Trust (72.8%), NHS Cheshire and Merseyside Integrated Care Board (76.2%), and England (71.2%). Diagnostic waits over 6 weeks reached 26.6% for MRI and 11.5% for CT (England 21.4% and 9.9%). These acute provider figures describe wider system performance rather than PCN delivery.

    Pathways within standard (%)East CheshireStockportManchesterCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)81.0883.2180.0677.2579.32
    31-day treatment (96%)96.3097.3992.5495.7192.50
    62-day referral to treatment (85%)53.4174.6772.8576.2371.16
    Diagnostic waits over 6 weeks (%)East CheshireStockportManchesterEngland
    MRI26.621.4111.6821.40
    CT11.492.9314.669.92
    Echocardiography26.2417.464.9128.48
    Colonoscopy10.855.534.5130.83
    Gastroscopy10.255.3129.3529.02
    All 15 DM01 tests16.1714.088.9823.14
    Community services activityCheshire East residentsCheshire and Merseyside ICB
    Care contacts72,825541,280
    Referrals18,28097,150
    Patients with a contact21,910146,240

    Community services (residents of Cheshire East), Jun 2026 (provisional). Provisional June 2026 Community Services Dataset records show that adults aged 65+ accounted for 60.8% of all community service contacts among Cheshire East residents (44,295 of 72,825 contacts). This activity reflects borough resident contacts rather than PCN-level service delivery, describing wider local authority demand rather than PCN performance.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, overall QOF achievement spans 93.3% at High Street Surgery to 100.0% at South Park Surgery (England 92.5%). Vaccination and immunisation domain achievement varies by 30.3 pp, from 69.7% at Park Green Surgery to 100.0% at South Park Surgery (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Park Lane Surgery1084.575.2%67.0%90.5%
    Cumberland House1204.957.4%73.2%87.7%
    South Park Surgery1225.281.7%77.6%86.1%
    Broken Cross886.279.0%59.2%85.1%
    Park Green Surgery1164.968.8%74.3%83.7%
    High Street1045.988.1%67.2%82.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCheshire East (LAD)AssetPCNCheshire East (LAD)
    Care homes (catchment)21 (809 beds)n/aSchools (catchment)66n/a
    Children's centres314Places of worship45272
    Libraries216Day centres (VCS)n/a1
    Children and young people (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)741Primary academies1478
    Special schools15

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma annual review recall

    Asthma annual review coverage is 68.3% (England 65.7%), falling 1.0% over 2023 to 2025 (England +4.4%), leaving 1,384 (about 1,400) of 4,363 registered patients unreviewed. For discussion: practices could run a standardised recall search and offer flexible review slots alongside inhaler prescribing checks. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Heart failure case-finding and review

    Recorded heart failure prevalence is 1.1% (661 of 62,807 patients) against 1.7% in Cheshire East and 1.1% in England, a modelled gap of +29 to +380 patients; reviews fell 1.6% over 2023 to 2025 (England +8.7%). Moderate effort to run.

    Option 3

    COPD annual review recovery

    COPD annual review coverage is 73.1% across the 1,342-patient register, below Cheshire East (74.5%) and England (76.4%) after falling 4.2% over 2023 to 2025 (England +2.8%). For discussion: practices could run targeted recall for overdue COPD patients and raise diagnostic spirometry capacity with system partners where confirmation is needed. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Hypertension patients with a recent blood pressure readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Early cancer diagnosis review (p7)Cancers diagnosed at stage 1 or 2 (All cancer sites) · Cancers with a known stage (All cancer sites)—ICB
    Option 1 · Asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Heart failure case-finding and review (p12)Heart failure register · Heart Failure: QOF prevalence · Registered population—PCN
    Option 3 · COPD annual review recovery (p12)COPD register · COPD patients with a review in the last 12 months · Patients with COPD who had a review in the last 12 months (denominator incl. PCAs)Core20PLUS5 approach · Tobacco and Vapes BillPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15